|
1
|
Villanueva A and Llovet JM: Targeted
therapies for hepatocellular carcinoma. Gastroenterology.
140:1410–1426. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jousilahti P, Salomaa V, Kuulasmaa K,
Niemela M and Vartiainen E: Total and cause specific mortality
among participants and non-participants of population based health
surveys: a comprehensive follow up of 54 372 Finnish men and women.
J Epidemiol Community Health. 59:310–315. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gray L, Batty GD, Craig P, et al: Cohort
profile: the Scottish health surveys cohort: linkage of study
participants to routinely collected records for mortality, hospital
discharge, cancer and offspring birth characteristics in three
nationwide studies. Int J Epidemiol. 39:345–350. 2010. View Article : Google Scholar
|
|
4
|
Veeck J, Niederacher D, An H, et al:
Aberrant methylation of the Wnt antagonist SFRP1 in breast cancer
is associated with unfavourable prognosis. Oncogene. 25:3479–3488.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Beaumont T and Leadbeater M: Treatment and
care of patients with metastatic breast cancer. Nurs Stand.
25:49–56. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dai C and Gu W: p53 post-translational
modification: deregulated in tumorigenesis. Trends Mol Med.
16:528–536. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zegarra-Moro OL, Schmidt LJ, Huang H and
Tindall DJ: Disruption of androgen receptor function inhibits
proliferation of androgen-refractory prostate cancer cells. Cancer
Res. 62:1008–1013. 2002.PubMed/NCBI
|
|
8
|
Zhang H, Pan Y, Zheng L, et al: FOXO1
inhibits Runx2 transcriptional activity and prostate cancer cell
migration and invasion. Cancer Res. 71:3257–3267. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhao Y, Kong X, Li X, et al: Metadherin
mediates lipopolysaccharide-induced migration and invasion of
breast cancer cells. PLoS One. 6:e293632011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Martini M, Gnann A, Scheikl D, Holzmann B
and Janssen KP: The candidate tumor suppressor SASH1 interacts with
the actin cytoskeleton and stimulates cell-matrix adhesion. Int J
Biochem Cell Biol. 43:1630–1640. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen EG, Chen Y, Dong LL and Zhang JS:
Effects of SASH1 on lung cancer cell proliferation, apoptosis, and
invasion in vitro. Tumour Biol. April 10–2012.(E-pub ahead of
print).
|
|
12
|
Zeller C, Hinzmann B, Seitz S, et al:
SASH1: a candidate tumor suppressor gene on chromosome 6q24.3 is
downregulated in breast cancer. Oncogene. 22:2972–2983. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rimkus C, Martini M, Friederichs J, et al:
Prognostic significance of downregulated expression of the
candidate tumour suppressor gene SASH1 in colon cancer. Br J
Cancer. 95:1419–1423. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Coleman TR and Dunphy WG: Cdc2 regulatory
factors. Curr Opin Cell Biol. 6:877–882. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Morgan DO: Cyclin-dependent kinases:
engines, clocks, and microprocessors. Annu Rev Cell Dev Biol.
13:261–291. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Krek W and Nigg EA: Mutations of p34cdc2
phosphorylation sites induce premature mitotic events in HeLa
cells: evidence for a double block to p34cdc2 kinase activation in
vertebrates. EMBO J. 10:3331–3341. 1991.
|
|
17
|
Dai X, Yamasaki K, Yang L, et al:
Keratinocyte G2/M growth arrest by 1,25-dihydroxyvitamin D3 is
caused by Cdc2 phosphorylation through Wee1 and Myt1 regulation. J
Invest Dermatol. 122:1356–1364. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ray G, Dhar G, Van Veldhuizen PJ, et al:
Modulation of cell-cycle regulatory signaling network by
2-methoxyestradiol in prostate cancer cells is mediated through
multiple signal transduction pathways. Biochemistry. 45:3703–3713.
2006. View Article : Google Scholar
|
|
19
|
Liu X, He H, Feng Y, Zhang M, Ren K and
Shao R: Difference of cell cycle arrests induced by lidamycin in
human breast cancer cells. Anticancer Drugs. 17:173–179. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Seo HR, Lee DH, Lee HJ, et al: Cyclin G1
overcomes radiation-induced G2 arrest and increases cell death
through transcriptional activation of cyclin B1. Cell Death Differ.
13:1475–1484. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tang L, Zhang Y, Pan H, et al: Involvement
of cyclin B1 in progesterone-mediated cell growth inhibition, G2/M
cell cycle arrest, and apoptosis in human endometrial cell. Reprod
Biol Endocrinol. 7:1442009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Passalaris TM, Benanti JA, Gewin L, Kiyono
T and Galloway DA: The G(2) checkpoint is maintained by redundant
pathways. Mol Cell Biol. 19:5872–5881. 1999.PubMed/NCBI
|
|
23
|
McGowan CH and Russell P: Cell cycle
regulation of human WEE1. EMBO J. 14:2166–2175. 1995.PubMed/NCBI
|
|
24
|
Wang XM, Li J, Feng XC, Wang Q, Guan DY
and Shen ZH: Involvement of the role of Chk1 in lithium-induced
G2/M phase cell cycle arrest in hepatocellular carcinoma cells. J
Cell Biochem. 104:1181–1191. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ryu MS, Lee MS, Hong JW, Hahn TR, Moon E
and Lim IK: TIS21/BTG2/PC3 is expressed through PKC-delta pathway
and inhibits binding of cyclin B1-Cdc2 and its activity,
independent of p53 expression. Exp Cell Res. 299:159–170. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Paulsen MT, Starks AM, Derheimer FA, et
al: The p53-targeting human phosphatase hCdc14A interacts with the
Cdk1/cyclin B complex and is differentially expressed in human
cancers. Mol Cancer. 5:252006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bunz F, Dutriaux A, Lengauer C, et al:
Requirement for p53 and p21 to sustain G2 arrest after DNA damage.
Science. 282:1497–1501. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yang PM, Huang WC, Lin YC, et al: Loss of
IKKbeta activity increases p53 stability and p21 expression leading
to cell cycle arrest and apoptosis. J Cell Mol Med. 14:687–698.
2010.PubMed/NCBI
|
